SCHEDULE: Clover Wolf Capital Discloses 7.5% Stake in NewcelX Ltd.

Clover Wolf Capital and Adi Wolf have jointly reported a 7.5% passive ownership stake in NewcelX Ltd., holding 343,120 common shares.

Summary

• Clover Wolf Capital Limited Partnership and Adi Wolf (Reporting Persons) have filed a Schedule 13G, disclosing their beneficial ownership in NewcelX Ltd.
• The Reporting Persons collectively beneficially own 343,120 Common Shares of NewcelX Ltd.
• This ownership represents a 7.5% stake in the company's outstanding Common Shares.
• The investment is passive, with the Reporting Persons certifying that the securities were not acquired and are not held for the purpose of changing or influencing the control of NewcelX Ltd.
• The percentage of ownership is based on 4,558,378 Common Shares issued and outstanding as of October 31, 2025, as previously reported by NewcelX Ltd. in a Form 6-K.
• Adi Wolf holds sole voting and dispositive power over the shares held by Clover Wolf Capital Limited Partnership.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The filing is a factual disclosure of ownership. The positive aspect stems from a significant institutional investor taking a passive stake, which can be interpreted as a vote of confidence, but it does not provide operational or financial performance details of NewcelX Ltd.

Positives

• A significant institutional investor, Clover Wolf Capital, along with Adi Wolf, has taken a substantial passive stake in NewcelX Ltd., potentially signaling confidence in the company's long-term prospects.
• The passive nature of the investment indicates a long-term holding strategy rather than an activist intent, which can provide stability.

Future Outlook

The filing does not contain any forward-looking statements or guidance from NewcelX Ltd. or the reporting persons regarding the issuer's future performance or strategic direction, beyond the passive nature of the investment.

Management Comments

• The Reporting Persons certified that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.

Industry Context

This filing indicates an institutional investor's decision to take a significant passive stake in NewcelX Ltd. without signaling any intent for active engagement or corporate governance changes. Such Schedule 13G filings are common for long-term investors accumulating positions in public companies, reflecting a belief in the company's underlying value.

Comparison to Industry Standards

• This is a standard Schedule 13G filing for passive ownership exceeding 5% of a company's outstanding shares. There are no specific operational or financial results to compare against industry benchmarks or competitors within this filing.
• The 7.5% ownership stake is a notable position for a single investor group, indicating a significant commitment to NewcelX Ltd.

Stakeholder Impact

• Shareholders: May view the disclosure of a significant passive stake by Clover Wolf Capital and Adi Wolf as a positive signal of investor confidence in NewcelX Ltd.

Next Steps

• The Reporting Persons will be responsible for timely filing subsequent amendments to this Schedule 13G if there are material changes to their beneficial ownership, such as an increase or decrease of 1% or more.

Key Dates

Recommendation

This Schedule 13G filing indicates a significant passive stake by Clover Wolf Capital and Adi Wolf in NewcelX Ltd. While the acquisition of a 7.5% stake by an institutional investor can be seen as a positive signal of confidence, the filing itself does not provide new operational or financial data to warrant a 'buy' or 'sell' recommendation. It primarily serves as a disclosure of ownership. Investors should 'hold' and monitor future company performance and any further disclosures from this investor group.

Keywords

NewcelX Ltd., Clover Wolf Capital, Adi Wolf, Schedule 13G, Passive Investment, Share Ownership, Institutional Investor, Common Shares, Equity Stake, SEC Filing